Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan Portfolio

Executive Summary

• Britannia Life Sciences Inc. completed a strategic investment of approximately $5.3 million in a portfolio of fully performing senior secured commercial equipment loans.
• The acquisition was made at an opportunistic discount to face value and is projected to generate over $2 million in free cash flow over the next 12 months, funding operational growth without additional financing.
• The transaction aligns with the company's venture builder strategy, leveraging proprietary capital alongside external capital to scale its asset-backed lending platform and build future operating businesses.

Key Details

• Investment Amount & Structure: Approximately $5.3 million deployed into a portfolio of senior secured commercial equipment loans.
• Portfolio Quality: All underlying loans are fully performing as of closing.
• Underwriting Focus: Conservative loan-to-value ratios, strong collateral coverage, and contracted borrower payments providing meaningful coverage of scheduled debt service.
• Acquisition Pricing: Purchased at an opportunistic discount to face value, capitalizing on current market dislocation and repricing in segments of the non-bank commercial lending market.
• Cash Flow Impact: Expected to generate in excess of $2 million in free cash flow over the coming twelve months.
• Capital Allocation & Use of Proceeds: Generated recurring cash flow will fund working capital requirements and support further expansion of the lending platform without reliance on additional external financing.
• Strategic Alignment: Consistent with the company's venture builder strategy of pairing proprietary capital with external capital to build and scale operating businesses, mirroring the successful model used for Paragon Advanced Labs Inc. (TSXV: PALS).
• Business Development & Lending Platform: Continued progress in scaling the asset-backed lending business through organic origination, additional opportunistic portfolio acquisitions, and strategic partnerships, with a focus on shorter-duration, well-collateralized assets.